Pre & Clinical Labs
CanCog Technologies
Custom Biologics
MuriGenics, Inc.
NoAb BioDiscoveries
Pre-Clinical Research Svcs
Xenometrics, LLC
CoreRx
Pre-Clinical Services
DMPK
Tox & Safety Pharm
Pharmacology
Bioanalytical
Animal Health Studies
Chemistry, Mfg. & Control
NextGen News
Xenometrics is pleased to announce its acquisition of the US toxicology unit of Bayer CropScience LP. The former Bayer CropScience unit will operate as the toxicology unit of Xenometrics. Alfred Botchway, Ph.D., President and Founder of Xenometrics said “We are excited to add the deep knowledge of toxicology that the Bayer CropScience study directors and technical staff bring to Xenometrics. The staff has been performing toxicology studies for more than two decades, and we are excited to offer this expertise to our customers.”
Complete Range of Outsourcing Options
NextGen Pharma Technologies, Inc. provides sales representation for innovative and niche CROs to Pharmaceutical and Biotechnology R&D decision makers. NextGen offers a complete range of outsourcing options - from discovery support through IND/NDA support and beyond. NextGen represents companies with new innovative technologies that improve lead optimization and drug candidate selection using: Screening GeneTox; Predictive ADME; in vivo efficacy; safety pharmacology (xenografts); behavioral pharmacology; drug development support such a GLP, Toxicology, ADME - rodents to NHP’s; formulation development; clinical supply manufacturing; GLP bioanalytical support; GLP protein and peptide analysis. These technologies can reduce development time and cost. In these uncertain economic times, NG clients offer a lower cost/higher value alternative to large multi-disciplined CROs.
For an overview of NextGen companies click here.